The CoPS study [COVID-19]
Research type
Research Study
Full title
Prevalence and persistence of SARS-CoV-2 in stool of COVID-19 positive subjects
IRAS ID
284252
Contact name
Arjan Narbad
Contact email
Sponsor organisation
Quadram Institute Bioscience
Duration of Study in the UK
2 years, 0 months, 1 days
Research summary
This is a research study carried out at the Quadram Institute Bioscience in collaboration with the Norfolk and Norwich University Hospital.\nThis is a longitudinal study in which participants that have been confirmed by an NHS swab test as COVID-19 positive will be asked to provide faecal and saliva samples, and complete short health/lifestyle questionnaires at the time of sampling. The number of samples collected from any participant will be dependent on how long the SARS-CoV-2 virus persists within the gut/stool, but will not exceed 8 of each sample type. We will aim to recruit up to 200 participants, and, to get the desired numbers, it may be necessary to continue recruitment during any further UK COVID-19 infection peaks. These samples will be primarily used to verify the persistence of the SARS-CoV-2 virus in the faeces, with whole genome sequencing also being used for viral strain analyses.\nThe research sponsor of this study is the Quadram Institute Bioscience.
REC name
HSC REC A
REC reference
20/NI/0076
Date of REC Opinion
2 Jun 2020
REC opinion
Further Information Favourable Opinion